The US Food and Drug Administration (FDA) has granted 510(k) clearance to Becton, Dickinson and Company’s (BD) in-vitro diagnostic (IVD) device, FACSLyric flow cytometer system.

The device is cleared for use with BD Multitest assays to immunologically assess patients with or suspected of having an immune deficiency.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

FACSLyric is a benchtop-sized instrument that works with a combination of software, reagents and services to deliver precise, reliable and repeatable results.

BD Biosciences president John Ledek said: "The FDA clearance of the BD FACSLyric system continues BD's drive to increase access to new innovations in clinical flow cytometry technology to more labs around the world.

"BD recognises that products for the clinical market require ease of use and standardisation from instrument to instrument to ensure consistent results that ultimately inform patient care."

"The FDA clearance of the BD FACSLyric system continues BD's drive to increase access to new innovations in clinical flow cytometry technology to more labs around the world."

Flow-based IVD assays, BD Multitest 4-Colour and Multitest 6-Colour TBNK that are designed to determine percentages, and absolute counts of T, B, natural killer (NK) cells, and the CD4 and CD8 subsets of T cells will be supported by the new diagnostic system.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Available in four configurations, the BD FACSLyric flow cytometer system was CE-Marked last year to the EU IVD Directive.

With operations in more than 50 countries, BD develops medical diagnostics and technologies for medical research and clinical laboratories.

The firm works to aid research and genomics, equipment for surgical and interventional procedures, diagnosis of infectious diseases and cancer, and prevention of infections.

Image: BD FACSLyric flow cytometer system. Photo: courtesy of PRNewsfoto/Becton, Dickinson and Company.